P Schoenfeld Asset Management LP Purchases New Stake in Kenvue Inc. $KVUE

P Schoenfeld Asset Management LP acquired a new position in shares of Kenvue Inc. (NYSE:KVUE) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 306,200 shares of the company’s stock, valued at approximately $5,851,482,000. Kenvue accounts for about 2.4% of P Schoenfeld Asset Management LP’s holdings, making the stock its 15th biggest position.

Several other large investors also recently made changes to their positions in the business. Johnson Financial Group Inc. acquired a new position in shares of Kenvue during the 2nd quarter valued at $26,000. CoreCap Advisors LLC raised its position in Kenvue by 64.9% in the second quarter. CoreCap Advisors LLC now owns 1,502 shares of the company’s stock valued at $29,000 after purchasing an additional 591 shares during the period. Elyxium Wealth LLC acquired a new position in shares of Kenvue during the fourth quarter worth about $26,000. Physician Wealth Advisors Inc. lifted its stake in shares of Kenvue by 67.5% during the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after purchasing an additional 618 shares in the last quarter. Finally, MV Capital Management Inc. purchased a new stake in shares of Kenvue in the fourth quarter worth about $28,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on KVUE shares. Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. UBS Group lowered their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Tuesday, August 11th. Zacks Research lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Wall Street Zen cut shares of Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Barclays upped their target price on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 21st. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Kenvue currently has a consensus rating of “Hold” and a consensus price target of $19.27.

Kenvue Trading Up 0.1%

Shares of KVUE opened at $19.08 on Monday. Kenvue Inc. has a one year low of $14.02 and a one year high of $21.78. The stock has a 50-day moving average price of $19.05 and a 200 day moving average price of $18.20. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01. The company has a market capitalization of $36.65 billion, a P/E ratio of 21.93, a P/E/G ratio of 1.36 and a beta of 0.47.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The business had revenue of $3.96 billion for the quarter, compared to analysts’ expectations of $3.97 billion. During the same quarter in the prior year, the firm earned $0.29 earnings per share. Kenvue’s revenue for the quarter was up 3.0% compared to the same quarter last year. Sell-side analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. This is a boost from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date is Wednesday, August 12th. Kenvue’s payout ratio is presently 96.55%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.